An Open-Label, Single-Dose, Randomized, Crossover Pharmacokinetics And Relative Bioavailability Study Of Three Modified 40 Mg Oxycodone Formulations Compared With 40 Mg Pf-00345439 Capsule Formulation In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2015
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 27 Jun 2012 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 27 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2012 Planned number of patients changed from 20 to 16 as reported by ClinicalTrials.gov.